American Century Companies, Inc. and affiliated entities filed Amendment No. 2 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership positions in DXC Technology Company (NYSE:DXC) as of September 30, 2026.

Key Highlights

  • 7.5% ownership reported: American Century Investment Management, Inc. and American Century Companies, Inc. each reported beneficial ownership of 11,963,873 shares, representing 7.5% of DXC Technology's common stock.
  • ETF Trust position: American Century ETF Trust separately reported beneficial ownership of 11,488,337 shares, representing 7.2% of the class.
  • Sole voting and dispositive power: All reported shares for American Century Investment Management, Inc. and American Century Companies, Inc. carry sole voting power of 11,963,873 shares and sole dispositive power of 11,963,873 shares, with no shared voting or dispositive power reported.
  • Triggering event date: The filing identifies September 30, 2026 as the date of the event requiring this statement.
  • Stowers Institute involvement: Stowers Institute for Medical Research, which controls American Century Companies, Inc., is listed as a reporting person with the same 11,963,873 share position.
  • Ordinary course certification: The filers certified that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

American Century's Reported Holdings in DXC Technology as of September 30, 2026

According to the filing, four entities submitted this joint Schedule 13G amendment: American Century ETF Trust, American Century Investment Management, Inc. (ACIM), American Century Companies, Inc. (ACC), and Stowers Institute for Medical Research. DXC Technology Company, the issuer, is a global IT services provider headquartered at 20408 Bashan Drive, Suite 231, Ashburn, Virginia, 20147, according to the address listed in the filing.

The filing discloses that ACIM is a wholly-owned subsidiary of ACC and is registered as an investment adviser under Section 203 of the Investment Advisers Act of 1940. The Stowers Institute for Medical Research, a Delaware-organized entity, is identified as the controlling entity of ACC. All four reporting persons are organized or incorporated in Delaware, according to the filing. ACIM and ACC each reported identical aggregate beneficial ownership of 11,963,873 shares, while American Century ETF Trust reported a slightly lower aggregate amount of 11,488,337 shares.

The filing further states that "various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities." The filing adds that no single client advised by ACIM holds more than 5% of DXC Technology's common stock class. All reporting persons share a principal business address of 4500 Main Street, 9th Floor, Kansas City, Missouri 64111.

What Was Disclosed

This Amendment No. 2 to Schedule 13G, filed November 16, 2026, reports that American Century-affiliated entities held between 7.2% and 7.5% of DXC Technology's common stock as of September 30, 2026, with all voting and dispositive power held on a sole basis and no shared powers reported.